Literature DB >> 15843990

ATM haplotypes and associated mutations in Iranian patients with ataxia-telangiectasia: recurring homozygosity without a founder haplotype.

Mahnoush Babaei1, Midori Mitui, Eric R Olson, Richard A Gatti.   

Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive disorder caused by mutations in the ATM gene. The ATM gene spans more than 150 kb at chromosomal region 11q23.1 and encodes a product of 3,056 amino acids. The ATM protein is a serine/threonine protein kinase and is involved in oxidative stress, cell cycle control, and DNA repair. We analyzed the 11q22-23 haplotypes and associated mutations of 16 Iranian families. We utilized standardized short tandem repeat (STR) haplotypes to enhance mutation identification. In addition to the STR markers, single-nucleotide polymorphism haplotypes were determined, using three critical polymorphisms. The entire gene was screened sequentially by protein truncation testing, single-strand conformation polymorphism, and denaturing high-performance liquid chromatography to identify the disease-causing mutations. Of the expected 32 mutations, 25 (78%) were identified. All but two mutations led to a truncated or null form of the ATM protein (nonsense, splice site, or frameshift). Twelve mutations were identified for 15 haplotypes. Five mutations were novel. Mutations were located throughout the entire gene, with no clustering. Despite the absence of an Iranian founder mutation, three-fourths of the families were homozygous, suggesting that many undetected ATM mutations still exist in Iran. This study establishes a database for Iranian A-T families, and extends the global spectrum of ATM mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843990     DOI: 10.1007/s00439-005-1254-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  53 in total

1.  Consanguineous marriage in Iran.

Authors:  M Saadat; M Ansari-Lari; D D Farhud
Journal:  Ann Hum Biol       Date:  2004 Mar-Apr       Impact factor: 1.533

2.  Ataxia-telangiectasia: founder effect among north African Jews.

Authors:  S Gilad; A Bar-Shira; R Harnik; D Shkedy; Y Ziv; R Khosravi; K Brown; L Vanagaite; G Xu; M Frydman; M F Lavin; D Hill; D A Tagle; Y Shiloh
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

3.  Radiosensitivity of ataxia-telangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay.

Authors:  Y K Huo; Z Wang; J H Hong; L Chessa; W H McBride; S L Perlman; R A Gatti
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

Review 4.  ATM and related protein kinases: safeguarding genome integrity.

Authors:  Yosef Shiloh
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

Review 5.  Ataxia-telangiectasia, an evolving phenotype.

Authors:  Helen H Chun; Richard A Gatti
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

6.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals.

Authors:  Gene Yeo; Christopher B Burge
Journal:  J Comput Biol       Date:  2004       Impact factor: 1.479

Review 7.  Cancer risks in A-T heterozygotes.

Authors:  D F Easton
Journal:  Int J Radiat Biol       Date:  1994-12       Impact factor: 2.694

8.  Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.

Authors:  R A Gatti; I Berkel; E Boder; G Braedt; P Charmley; P Concannon; F Ersoy; T Foroud; N G Jaspers; K Lange
Journal:  Nature       Date:  1988-12-08       Impact factor: 49.962

9.  Exon-scanning mutation analysis of the ATM gene in patients with ataxia-telangiectasia.

Authors:  I Vorechovský; L Luo; S Prudente; L Chessa; G Russo; M Kanariou; M James; M Negrini; A D Webster; L Hammarström
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

10.  Early diagnosis of ataxia-telangiectasia using radiosensitivity testing.

Authors:  Xia Sun; Sara G Becker-Catania; Helen H Chun; Mee Jeong Hwang; Yong Huo; Zhijun Wang; Midori Mitui; Ozden Sanal; Luciana Chessa; Barbara Crandall; Richard A Gatti
Journal:  J Pediatr       Date:  2002-06       Impact factor: 4.406

View more
  5 in total

1.  BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia.

Authors:  Anna Isaian; Natalia V Bogdanova; Masoud Houshmand; Masoud Movahadi; Asghar Aghamohammadi; Asghar Agamohammadi; Nima Rezaei; Lida Atarod; Mahnaz Sadeghi-Shabestari; Seyed Hasan Tonekaboni; Zahra Chavoshzadeh; Seyed Mohammad Seyed Hassani; Reza Mirfakhrai; Taher Cheraghi; Najmoddin Kalantari; Mitra Ataei; Thilo Dork-Bousset; Mohammad Hossein Sanati
Journal:  J Clin Immunol       Date:  2009-11-07       Impact factor: 8.317

2.  Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.

Authors:  M Mitui; S A Nahas; L T Du; Z Yang; C H Lai; K Nakamura; S Arroyo; S Scott; A Purayidom; P Concannon; M Lavin; R A Gatti
Journal:  Hum Mutat       Date:  2009-01       Impact factor: 4.878

3.  Ten new ATM alterations in Polish patients with ataxia-telangiectasia.

Authors:  Marta Joanna Podralska; Agnieszka Stembalska; Ryszard Ślęzak; Aleksandra Lewandowicz-Uszyńska; Barbara Pietrucha; Sylwia Kołtan; Jadwiga Wigowska-Sowińska; Jacek Pilch; Maria Mosor; Iwona Ziółkowska-Suchanek; Agnieszka Dzikiewicz-Krawczyk; Ryszard Słomski
Journal:  Mol Genet Genomic Med       Date:  2014-07-30       Impact factor: 2.183

Review 4.  Against Lung Cancer Cells: To Be, or Not to Be, That Is the Problem.

Authors:  Naoko Okumura; Hitomi Yoshida; Yasuko Kitagishi; Yuri Nishimura; Shio Iseki; Satoru Matsuda
Journal:  Lung Cancer Int       Date:  2012-02-01

5.  Unusual clinical manifestations and predominant stopgain ATM gene variants in a single centre cohort of ataxia telangiectasia from North India.

Authors:  Amit Rawat; Rahul Tyagi; Himanshi Chaudhary; Vignesh Pandiarajan; Ankur Kumar Jindal; Deepti Suri; Anju Gupta; Madhubala Sharma; Kanika Arora; Amanjit Bal; Priyanka Madaan; Lokesh Saini; Jitendra Kumar Sahu; Yumi Ogura; Tamaki Kato; Kohsuke Imai; Shigeaki Nonoyama; Surjit Singh
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.